Cancer Research UK Cancer Awareness Measures, September 2022

<P>Abstract copyright UK Data Service and data collection copyright owner.</P><p>The <span style="font-style: italic;">Cancer Awareness Measure</span> (CAM) was developed in 2007-8 to address the absence of a validated measure of general public awareness of cancer (Stubbings, S., Robb, K., Waller, J., Ramirez, A., Austoker, J., Macleod, U., Hion, S., and Wardle, J. (2009) 'Development of a measurement tool to assess public awareness of cancer', British Journal of Cancer, 101(2), S13-S17.).<br><br>The survey includes measures of awareness of signs and symptoms of cancer, cancer risk factors, age-related risk, screening programmes and potential barriers to seeing the GP. Since then, Cancer Research UK (CRUK) has significantly revised and updated the survey, including a wider range of questions and collecting data online instead of face-to-face. The CAM was also previously known as the National Awareness and Early Diagnosis Initiative Cancer Awareness Measure (NAEDI-CAM).</p><br>&#10;<div class="x_x_x_OutlineElement x_x_x_Ltr x_x_x_SCXW166487263 x_x_x_BCX0">&#10;<p class="x_x_x_Paragraph x_x_x_SCXW166487263 x_x_x_BCX0">CAM data have been collected by CRUK approximately every two years from 2008 to 2019, moving to bi-annual in 2021. The COVID specific CAM was developed in 2020 and 2021 to measure the longitudinal impact of COVID-19 pandemic on cancer attitudes and behaviour and to understand the contextual influences on cancer attitudes and behaviour during the COVID-19 pandemic.<br><br>Further information about the CAM may be found on the&#160;<a href="https://www.cancerresearchuk.org/health-professional/awareness-and-prevention/the-cancer-awareness-measures-cam#CAM_Use3" target="_blank">Cancer Research UK Cancer Awareness Measures</a>&#160;(CAMs) webpage.<br></p></div><div class="x_x_x_OutlineElement x_x_x_Ltr x_x_x_SCXW166487263 x_x_x_BCX0">&#10;</div>&#10;<br><B>Main Topics</B>:<BR><br><br><p>The CAM questionnaire addressed the following topics:</p><ul><li>public awareness of cancer symptoms</li><li>public knowledge of cancer risk factors</li><li>barriers and enablers to help seeking</li><li>uptake of screening programmes (cervical, bowel, breast)</li><li>barriers to cancer screening (cervical, breast and bowel)</li><li>experience of breast and cervical cancer screening</li><li>symptom experience including further tests</li><li>impact of COVID-19 on help seeking behaviour</li><li>co-morbidities</li><li>perception of symptom seriousness</li><li>help seeking behaviours including remote consultation and re-presentation</li><li>perceptions of remote consultation</li></ul>